C. Ann Merrifield

Insider Reports History

Signature
/s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by C. Ann Merrifield:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyra Therapeutics, Inc. Director Restricted Stock Units 32K May 14, 2025 Direct
Lyra Therapeutics, Inc. Director Stock Option 30K Jun 13, 2024 Direct
INVIVO THERAPEUTICS HOLDINGS CORP. Director Stock Option (right to buy) 4.2K Nov 17, 2022 Direct
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc Director Stock option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by C. Ann Merrifield

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYRA Lyra Therapeutics, Inc. May 14, 2025 1 $0 4 May 16, 2025 Director
LYRA Lyra Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
LYRA Lyra Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
NVIV INVIVO THERAPEUTICS HOLDINGS CORP. Nov 17, 2022 1 $0 4 Nov 21, 2022 Director
LYRA Lyra Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
LYRA Lyra Therapeutics, Inc. Jun 10, 2022 1 $20.2K 4 Jun 13, 2022 Director
LYRA Lyra Therapeutics, Inc. May 13, 2022 2 $18.5K 4 May 17, 2022 Director
FLXN Flexion Therapeutics Inc Nov 19, 2021 9 -$162K 4 Nov 19, 2021 Director
FLXN Flexion Therapeutics Inc Jun 24, 2021 2 $0 4 Jun 28, 2021 Director
LYRA Lyra Therapeutics, Inc. Jun 17, 2021 1 $31.4K 4 Jun 22, 2021 Director
LYRA Lyra Therapeutics, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director